Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenguang Shen

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Emerging Microbes & Infections|March 7, 2022
A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunityXin Wang, Xiaochen Yin, Boya Zhang, et al.
Biomaterials|April 30, 2026
Engineered attenuated probiotic Escherichia coli oral vaccine provides effective protection against monkeypox virus by eliciting specific systemic and mucosal immunityHan Duan, Chenguang Shen, Xinting Fu, et al.
Science (New York, N.Y.)|May 15, 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Yan Wu, Feiran Wang, Chenguang Shen, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
National Science Review|October 22, 2021
Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injuryYingxia Liu, Cong Zhang, Fengming Huang, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
JAMA|March 29, 2020
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaChenguang Shen, Zhaoqin Wang, Fang Zhao, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Small Methods|February 22, 2021
Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound InhibitorsYali Zhang, Shaojuan Wang, Yangtao Wu, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Emerging Microbes & Infections|March 7, 2022
A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunityXin Wang, Xiaochen Yin, Boya Zhang, et al.
Biomaterials|April 30, 2026
Engineered attenuated probiotic Escherichia coli oral vaccine provides effective protection against monkeypox virus by eliciting specific systemic and mucosal immunityHan Duan, Chenguang Shen, Xinting Fu, et al.
Science (New York, N.Y.)|May 15, 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Yan Wu, Feiran Wang, Chenguang Shen, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
National Science Review|October 22, 2021
Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injuryYingxia Liu, Cong Zhang, Fengming Huang, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
JAMA|March 29, 2020
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaChenguang Shen, Zhaoqin Wang, Fang Zhao, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Small Methods|February 22, 2021
Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound InhibitorsYali Zhang, Shaojuan Wang, Yangtao Wu, et al.
Pageof 7